Asier Benito‐Vicente

5.2k total citations · 2 hit papers
40 papers, 3.2k citations indexed

About

Asier Benito‐Vicente is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Asier Benito‐Vicente has authored 40 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Surgery, 15 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Asier Benito‐Vicente's work include Lipoproteins and Cardiovascular Health (32 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Asier Benito‐Vicente is often cited by papers focused on Lipoproteins and Cardiovascular Health (32 papers), Protein Kinase Regulation and GTPase Signaling (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Asier Benito‐Vicente collaborates with scholars based in Spain, Portugal and United States. Asier Benito‐Vicente's co-authors include César Martı́n, Unai Galicia-García, Asier Larrea‐Sebal, Helena Ostolaza, Kepa B. Uribe, Shifa Jebari, Shifa Jebari‐Benslaiman, Iraide Alloza, Koen Vandenbroeck and Javier Rekondo Olaetxea and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Asier Benito‐Vicente

39 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathophysiology of Type 2 Diabetes Mellitus

2020 1.9k citations Unai Galicia-García, Asier Benito‐Vicente et al. International Journal of Molecular Sciences profile →
Pathophysiology of Atherosclerosis

2022 516 citations Shifa Jebari‐Benslaiman, Unai Galicia-García et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asier Benito‐Vicente Spain	19	993	973	913	498	404	40	3.2k
Unai Galicia-García Spain	14	665 0.7×	878 0.9×	839 0.9×	501 1.0×	398 1.0×	21	2.8k
Asier Larrea‐Sebal Spain	11	574 0.6×	854 0.9×	792 0.9×	488 1.0×	387 1.0×	22	2.7k
Federica Fogacci Italy	38	1.1k 1.1×	690 0.7×	946 1.0×	452 0.9×	401 1.0×	149	4.0k
Kepa B. Uribe Spain	17	655 0.7×	869 0.9×	793 0.9×	451 0.9×	335 0.8×	42	2.6k
Maria-Corina Șerban Romania	39	1.6k 1.6×	699 0.7×	760 0.8×	403 0.8×	472 1.2×	87	4.5k
Hidekatsu Yanai Japan	28	722 0.7×	927 1.0×	879 1.0×	709 1.4×	733 1.8×	174	3.7k
Jean Bergeron Canada	29	1.3k 1.3×	989 1.0×	512 0.6×	479 1.0×	466 1.2×	80	2.9k
Dragana Nikolić Italy	32	885 0.9×	1.0k 1.1×	710 0.8×	257 0.5×	387 1.0×	78	2.6k
Maureen Sampson United States	27	1.0k 1.1×	778 0.8×	548 0.6×	343 0.7×	439 1.1×	93	2.8k
Kjetil Retterstøl Norway	33	1.6k 1.7×	946 1.0×	520 0.6×	742 1.5×	302 0.7×	189	3.7k

Countries citing papers authored by Asier Benito‐Vicente

Since Specialization

Citations

This map shows the geographic impact of Asier Benito‐Vicente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asier Benito‐Vicente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asier Benito‐Vicente more than expected).

Fields of papers citing papers by Asier Benito‐Vicente

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asier Benito‐Vicente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asier Benito‐Vicente. The network helps show where Asier Benito‐Vicente may publish in the future.

Co-authorship network of co-authors of Asier Benito‐Vicente

This figure shows the co-authorship network connecting the top 25 collaborators of Asier Benito‐Vicente. A scholar is included among the top collaborators of Asier Benito‐Vicente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asier Benito‐Vicente. Asier Benito‐Vicente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Larrea‐Sebal, Asier, Shifa Jebari‐Benslaiman, Unai Galicia-García, et al.. (2024). OptiMo‐LDLr: An Integrated In Silico Model with Enhanced Predictive Power for LDL Receptor Variants, Unraveling Hot Spot Pathogenic Residues. Advanced Science. 11(13). e2305177–e2305177. 2 indexed citations

Larrea‐Sebal, Asier, Chiara Trenti, Shifa Jebari‐Benslaiman, et al.. (2023). Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject. International Journal of Molecular Sciences. 24(4). 3330–3330. 1 indexed citations

Suárez, Nicolás M., Asier Benito‐Vicente, Yeray Brito‐Casillas, et al.. (2023). Age, Origin and Functional Study of the Prevalent LDLR Mutation Causing Familial Hypercholesterolaemia in Gran Canaria. International Journal of Molecular Sciences. 24(14). 11319–11319. 1 indexed citations

Alves, Ana Catarina, Asier Benito‐Vicente, Unai Galicia-García, et al.. (2021). LDLR variants functional characterization: Contribution to variant classification. Atherosclerosis. 329. 14–21. 13 indexed citations

Benito‐Vicente, Asier, Shifa Jebari‐Benslaiman, Unai Galicia-García, et al.. (2021). Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction. International review of cell and molecular biology. 359. 357–402. 36 indexed citations

Galicia-García, Unai, Asier Benito‐Vicente, Kepa B. Uribe, et al.. (2020). Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR. Scientific Reports. 10(1). 1727–1727. 25 indexed citations

Galicia-García, Unai, Shifa Jebari, Asier Larrea‐Sebal, et al.. (2020). Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights. International Journal of Molecular Sciences. 21(13). 4725–4725. 92 indexed citations

Banerjee, Poulabi, Kuo‐Chen Chan, Asier Benito‐Vicente, et al.. (2019). Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity. Arteriosclerosis Thrombosis and Vascular Biology. 39(11). 2248–2260. 64 indexed citations

Sánchez-Hernández, Rosa M., Maria Donata Di Taranto, Asier Benito‐Vicente, et al.. (2019). The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9. Atherosclerosis. 289. 162–172. 19 indexed citations

10.

Alves, Ana Catarina, et al.. (2018). Further evidence of novel APOB mutations as a cause of familial hypercholesterolaemia. Atherosclerosis. 277. 448–456. 18 indexed citations

11.

Benito‐Vicente, Asier, Kepa B. Uribe, Shifa Jebari, et al.. (2018). Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants. International Journal of Molecular Sciences. 19(6). 1676–1676. 36 indexed citations

12.

Benito‐Vicente, Asier, Kepa B. Uribe, Shifa Jebari, et al.. (2018). p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro. Scientific Reports. 8(1). 16614–16614. 5 indexed citations

13.

Benito‐Vicente, Asier, Kepa B. Uribe, Shifa Jebari, et al.. (2018). Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition. PLoS ONE. 13(10). e0204771–e0204771. 1 indexed citations

14.

Jiang, Long, Wenfeng Wu, Panpan Chen, et al.. (2016). The use of targeted exome sequencing in genetic diagnosis of young patients with severe hypercholesterolemia. Scientific Reports. 6(1). 36823–36823. 13 indexed citations

15.

Benito‐Vicente, Asier, et al.. (2016). Structural changes induced by acidic pH in human apolipoprotein B-100. Scientific Reports. 6(1). 36324–36324. 12 indexed citations

16.

Benito‐Vicente, Asier, et al.. (2015). The importance of an integrated analysis of clinical, molecular, and functional data for the genetic diagnosis of familial hypercholesterolemia. Genetics in Medicine. 17(12). 980–988. 33 indexed citations

17.

Alves, Ana Catarina, et al.. (2015). Genetic diagnosis of familial hypercholesterolaemia: The importance of an integrated analysis of clinical, molecular and functional data. Atherosclerosis. 241(1). e111–e112. 1 indexed citations

18.

Etxebarria, Aitor, Asier Benito‐Vicente, Ana Catarina Alves, et al.. (2015). Structural analysis of APOB variants, p.(Arg3527Gln), p.(Arg1164Thr) and p.(Gln4494del), causing Familial Hypercholesterolaemia provides novel insights into variant pathogenicity. Scientific Reports. 5(1). 18184–18184. 27 indexed citations

19.

Etxebarria, Aitor, Asier Benito‐Vicente, Ana Catarina Alves, et al.. (2014). Advantages and Versatility of Fluorescence-Based Methodology to Characterize the Functionality of LDLR and Class Mutation Assignment. PLoS ONE. 9(11). e112677–e112677. 27 indexed citations

20.

Etxebarria, Aitor, et al.. (2014). Activity-associated effect of LDL receptor missense variants located in the cysteine-rich repeats. Atherosclerosis. 238(2). 304–312. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact